# ===========================================================================
#
#                            PUBLIC DOMAIN NOTICE
#               National Center for Biotechnology Information
#
#  This software/database is a "United States Government Work" under the
#  terms of the United States Copyright Act.  It was written as part of
#  the author's official duties as a United States Government employee and
#  thus cannot be copyrighted.  This software/database is freely available
#  to the public for use. The National Library of Medicine and the U.S.
#  Government have not placed any restriction on its use or reproduction.
#
#  Although all reasonable efforts have been taken to ensure the accuracy
#  and reliability of the software and data, the NLM and the U.S.
#  Government do not and cannot warrant the performance or results that
#  may be obtained by using this software or data. The NLM and the U.S.
#  Government disclaim all warranties, express or implied, including
#  warranties of performance, merchantability or fitness for any particular
#  purpose.
#
#  For daily update, we screen the search results of this PubMed query:
#  "coronavirus"[All Fields] OR "ncov"[All Fields] OR "cov"[All Fields] OR
#  "2019-nCoV"[All Fields] OR "COVID-19"[All Fields] OR "SARS-CoV-2"[All Fields].
#  Relevant articles are identified and curated with assistance from an automated
#  machine-learning and text-classification algorithm.
#
#  Please cite the authors in any work or product based on this material :
#
#  Chen Q, Allot A, & Lu Z. (2020) Keep up with the latest coronavirus research, Nature 579:193
#
#  Chen Q, Allot A, Lu Z. LitCovid: an open database of COVID-19 literature. Nucleic Acids Research. 2020.
#
# ==========================================================================
pmid	title_e	journal
36140425	The JAK1/2 Inhibitor Baricitinib Mitigates the Spike-Induced Inflammatory Response of Immune and Endothelial Cells In Vitro.	Biomedicines
36048718	Insights into functional connectivity in mammalian signal transduction pathways by pairwise comparison of protein interaction partners of critical signaling hubs.	Biomol Concepts
36029717	COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman.	J Autoimmun
35998224	Single-cell RNA sequencing uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19.	Proc Natl Acad Sci U S A
35972291	XAF1 Protects Host against Emerging RNA Viruses by Stabilizing IRF1-Dependent Antiviral Immunity.	J Virol
35970938	Structural basis for Sarbecovirus ORF6 mediated blockage of nucleocytoplasmic transport.	Nat Commun
35933402	USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING.	Cell Death Dis
35896528	A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions.	Nat Commun
35855804	Reveal the Mechanisms of Yi-Fei-Jian-Pi-Tang on Covid-19 through Network Pharmacology Approach.	Comput Intell Neurosci
35844575	Antigenic Determinants of SARS-CoV-2-Specific CD4(+) T Cell Lines Reveals M Protein-Driven Dysregulation of Interferon Signaling.	Front Immunol
35842705	A comprehensive evaluation of the immune system response and type-I Interferon signaling pathway in hospitalized COVID-19 patients.	Cell Commun Signal
35818398	Systems biology models to identify the influence of SARS-CoV-2 infections to the progression of human autoimmune diseases.	Inform Med Unlocked
35746745	Nucleopore Traffic Is Hindered by SARS-CoV-2 ORF6 Protein to Efficiently Suppress IFN-beta and IL-6 Secretion.	Viruses
35740960	A Novel Antiviral Protein Derived from Oenanthe javanica: Type I Interferon-Dependent Antiviral Signaling and Its Pharmacological Potential.	Biomolecules
35645319	TNF-alpha/IFN-gamma synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1.	Aging Cell
35590097	SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication.	Commun Biol
35558069	Landscape of Peripheral Blood Mononuclear Cells and Soluble Factors in Severe COVID-19 Patients With Pulmonary Fibrosis Development.	Front Immunol
35456913	STAT1 and Its Crucial Role in the Control of Viral Infections.	Int J Mol Sci
35454970	Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm.	Life (Basel)
35317858	SARS-CoV-2 NSP13 helicase suppresses interferon signaling by perturbing JAK1 phosphorylation of STAT1.	Cell Biosci
35306855	Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment.	Immunotherapy
35277538	Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.	Sci Rep
35187564	Decoupling SARS-CoV-2 ORF6 localization and interferon antagonism.	J Cell Sci
35127768	The Potential Bioactive Components of Nine TCM Prescriptions Against COVID-19 in Lung Cancer Were Explored Based on Network Pharmacology and Molecular Docking.	Front Med (Lausanne)
35085552	Elimination of Aicardi-Goutieres syndrome protein SAMHD1 activates cellular innate immunity and suppresses SARS-CoV-2 replication.	J Biol Chem
35083167	SARS-CoV-2 Spike Antagonizes Innate Antiviral Immunity by Targeting Interferon Regulatory Factor 3.	Front Cell Infect Microbiol
35044570	The Priming Potential of Interferon Lambda-1 for Antiviral Defense in the Oral Mucosa.	Inflammation
34992355	Potential Molecular Mechanisms and Remdesivir Treatment for Acute Respiratory Syndrome Corona Virus 2 Infection/COVID 19 Through RNA Sequencing and Bioinformatics Analysis.	Bioinform Biol Insights
34950606	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) and Spike (S) Proteins Antagonize Host Type I Interferon Response.	Front Cell Infect Microbiol
34943787	SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells.	Cells
34880855	Transcriptional Profiling and Machine Learning Unveil a Concordant Biosignature of Type I Interferon-Inducible Host Response Across Nasal Swab and Pulmonary Tissue for COVID-19 Diagnosis.	Front Immunol
34878838	TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection.	Sci Adv
34877479	Roles of antiviral sensing and type I interferon signaling in the restriction of SARS-CoV-2 replication.	iScience
34835005	Apoptosis Enhances the Replication of Human Coronavirus OC43.	Viruses
34782627	SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis.	Nat Commun
34757528	Network Meta-analysis on the Changes of Amyloid Precursor Protein Expression Following SARS-CoV-2 Infection.	J Neuroimmune Pharmacol
34718945	Immunogenicity and Safety of COVID-19 mRNA Vaccine in STAT1 GOF Patients.	J Clin Immunol
34687317	Interactome profiling reveals interaction of SARS-CoV-2 NSP13 with host factor STAT1 to suppress interferon signaling.	J Mol Cell Biol
34676541	Altered increase in STAT1 expression and phosphorylation in severe COVID-19.	Eur J Immunol
34650546	ORF3a Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Inhibits Interferon-Activated Janus Kinase/Signal Transducer and Activator of Transcription Signaling via Elevating Suppressor of Cytokine Signaling 1.	Front Microbiol
34639073	Molecular Mechanism of the Anti-Inflammatory Action of Heparin.	Int J Mol Sci
34471099	A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response.	Signal Transduct Target Ther
34445373	SARS-CoV-2: Understanding the Transcriptional Regulation of ACE2 and TMPRSS2 and the Role of Single Nucleotide Polymorphism (SNP) at Codon 72 of p53 in the Innate Immune Response against Virus Infection.	Int J Mol Sci
34437657	SARS-CoV-2 suppresses IFNbeta production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon.	PLoS Pathog
34400346	Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx.	Mol Cell Proteomics
34312772	Genetic Exchange of Lung-Derived Exosome to Brain Causing Neuronal Changes on COVID-19 Infection.	Mol Neurobiol
34228987	SARS-CoV-2 Spike protein enhances ACE2 expression via facilitating Interferon effects in bronchial epithelium.	Immunol Lett
34209818	Toward a Coronavirus Knowledge Graph.	Genes (Basel)
34153860	Lack of active SARS-CoV-2 virus in a subset of PCR-positive COVID-19 congregate care patients.	J Clin Virol
34109505	SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance?	J Clin Immunol
34107055	Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS-CoV-2 Spike protein.	Eur J Immunol
34064383	Control of Macrophage Inflammation by P2Y Purinergic Receptors.	Cells
34061776	Mild COVID-19 despite autoantibodies against type I IFNs in autoimmune polyendocrine syndrome type 1.	J Clin Invest
33991637	Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy.	J Hepatol
33950285	Histomorphological patterns of regional lymph nodes in COVID-19 lungs.	Pathologe
33907801	Analyzing master regulators and scRNA-seq of COVID-19 patients reveals an underlying anti-SARS-CoV-2 mechanism of ZNF proteins.	Brief Bioinform
33882442	Immunopharmacological perspective on zinc in SARS-CoV-2 infection.	Int Immunopharmacol
33879239	IFN-gamma and TNF-alpha drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation.	Genome Med
33827897	SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation.	Sci Immunol
33815692	COVID-19 co-infection mathematical model as guided through signaling structural framework.	Comput Struct Biotechnol J
33705988	Loss of sarcomeric proteins via upregulation of JAK/STAT signaling underlies interferon-gamma-induced contractile deficit in engineered human myocardium.	Acta Biomater
33688586	In silico analysis of altered expression of long non-coding RNA in SARS-CoV-2 infected cells and their possible regulation by STAT1, STAT3 and interferon regulatory factors.	Heliyon
33688079	Identification of human immune cell subtypes most responsive to IL-1beta-induced inflammatory signaling using mass cytometry.	Sci Signal
33575887	[Histomorphological patterns of regional lymph nodes in COVID-19 lungs].	Pathologe
33520684	Analyzing the potential therapeutic mechanism of Huashi Baidu Decoction on severe COVID-19 through integrating network pharmacological methods.	J Tradit Complement Med
33520015	Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools.	Eur J Integr Med
33504682	Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection.	Biomol Ther (Seoul)
33419885	Influenza virus infection increases ACE2 expression and shedding in human small airway epithelial cells.	Eur Respir J
33414457	Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections.	Cell Death Dis
33362771	A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.	Front Immunol
33278357	Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.	Cell
33251388	High affinity of host human microRNAs to SARS-CoV-2 genome: An in silico analysis.	Noncoding RNA Res
33251083	Identification of potential mRNA panels for severe acute respiratory syndrome coronavirus 2 (COVID-19) diagnosis and treatment using microarray dataset and bioinformatics methods.	3 Biotech
33242255	An integrative analysis identifying transcriptional features and key genes involved in COVID-19.	Epigenomics
33112891	Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2.	PLoS One
33097660	SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.	Proc Natl Acad Sci U S A
33054436	Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus pneumonia (COVID-19).	Drug Dev Ind Pharm
33037393	An aberrant STAT pathway is central to COVID-19.	Cell Death Differ
32979938	Evasion of Type I Interferon by SARS-CoV-2.	Cell Rep
32953130	SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2.	Cell Discov
32938761	Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.	J Virol
32783921	Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.	Immunity
32676080	"Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-gamma, IL-17A, and a Janus Kinase Inhibitor.	Front Immunol
32643603	Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.	Cell
32563187	Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.	J Infect Dis
32549200	A Putative Role of de-Mono-ADP-Ribosylation of STAT1 by the SARS-CoV-2 Nsp3 Protein in the Cytokine Storm Syndrome of COVID-19.	Viruses
32547891	Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection.	PeerJ
32489026	[Intervention mechanism of Qingwen Baidu Yin on cytokine storm based on network pharmacology].	Zhongguo Zhong Yao Za Zhi
